Ling Wang (L Wang)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Molecules (Basel, Switzerland)

Pharmaceutical research

Pharmaceutics

Nano letters

Sichuan University

Sichuan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sichuan University

China

associate professor :: West China School of Pharmacy

Education History

Sichuan University

China

PHD :: West China School of Pharmacy

Sichuan University

China

BSC :: West China School of Pharmacy

Publications

Yu Yan, Bin Wu, Ling Wang
A real-world pharmacovigilance study of QT interval prolongation and Torsades de Pointes associated with CDK4/6 inhibitors in breast cancer patients: findings from the FDA adverse event reporting system. Expert opinion on drug safety (2024)
Chaozhuang Shen, Hongyi Yang, Wenxin Shao, Liang Zheng, Wei Zhang, Haitang Xie, Xuehua Jiang, Ling Wang
Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms. Pharmaceutical research 41 (4) (2024)
Chaozhuang Shen, Hongyi Yang, Wenxin Shao, Liang Zheng, Wei Zhang, Haitang Xie, Xuehua Jiang, Ling Wang
Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms. Pharmaceutical research (2024)
Chaozhuang Shen, Hongyi Yang, Wenxin Shao, Liang Zheng, Wei Zhang, Haitang Xie, Xuehua Jiang, Ling Wang
Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms. Pharmaceutical research 41 (4) (2024)
Wenwen Xu, Yumeng Xiao, Liang Zheng, Mingyu Xu, Xuehua Jiang, Ling Wang
Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein. Pharmaceutics 15 (12) (2023)
Liang Ni, Liang Zheng, Yueyue Liu, Wenwen Xu, Yingjie Zhao, Ling Wang, Qian Zhang, Wei Hu, Xijing Chen
Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib. Advances in therapy (2023)
Wenwen Xu, Yumeng Xiao, Liang Zheng, Mingyu Xu, Xuehua Jiang, Ling Wang
Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein. Pharmaceutics 15 (12) (2023)
Weipei Yang, Zhongxu Liang, Chengming Wen, Xuehua Jiang, Ling Wang
Silymarin Protects against Acute Liver Injury Induced by Acetaminophen by Downregulating the Expression and Activity of the CYP2E1 Enzyme. Molecules (Basel, Switzerland) 27 (24) (2022)
L Liu, Y Yang, W Li, Y Li, X Jiang, Ling Wang
Tanshinone IIA alleviate rifampicin-induced cholestasis by regulating the expression and function of bile salt export pump. Human & experimental toxicology 41 (2022)
Weipei Yang, Zhongxu Liang, Chengming Wen, Xuehua Jiang, Ling Wang
Silymarin Protects against Acute Liver Injury Induced by Acetaminophen by Downregulating the Expression and Activity of the CYP2E1 Enzyme. Molecules (Basel, Switzerland) 27 (24) (2022)
Weipei Yang, Zhongxu Liang, Chengming Wen, Xuehua Jiang, Ling Wang
Silymarin Protects against Acute Liver Injury Induced by Acetaminophen by Downregulating the Expression and Activity of the CYP2E1 Enzyme. Molecules (Basel, Switzerland) 27 (24) (2022)
Weipei Yang, Zhongxu Liang, Chengming Wen, Xuehua Jiang, Ling Wang
Silymarin Protects against Acute Liver Injury Induced by Acetaminophen by Downregulating the Expression and Activity of the CYP2E1 Enzyme. Molecules (Basel, Switzerland) 27 (24) (2022)
Wei Xiong, Ling Wang, Haiyan Zhang, Xiaoqiu Tao, Xuehua Jiang, Zejuan Liu, Jiajia Zhao, Wenwen Xu
Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies. Journal of analytical methods in chemistry 2021 (2021)
Miao Xu, Liang Zheng, Jin Zeng, Wenwen Xu, Xuehua Jiang, Ling Wang
Physiologically based pharmacokinetic modeling of tramadol to inform dose adjustment and drug-drug interactions according to CYP2D6 phenotypes. Pharmacotherapy 41 (3) (2021)
Chengming Wen, Haoyang Hu, Wenwen Zhang, Xin Liu, Xuehua Jiang, Ling Wang
Assessing CYP2C8-Mediated Pharmaceutical Excipient-Drug Interaction Potential: A Case Study of Tween 80 and Cremophor EL-35. Pharmaceutics 13 (9) (2021)
Lu Yu, Xu Chen, Wen Sheng Zhang, Liang Zheng, Wen Wen Xu, Ming Yu Xu, Xue Hua Jiang, Ling Wang
Metabolite identification, tissue distribution, excretion and preclinical pharmacokinetic studies of ET-26-HCl, a new analogue of etomidate. Royal Society open science 7 (2) (2020)
Liang Zheng, Shiwei Tang, Rui Tang, Miao Xu, Xuehua Jiang, Ling Wang
Dose Adjustment of Quetiapine and Aripiprazole for Pregnant Women Using Physiologically Based Pharmacokinetic Modeling and Simulation. Clinical pharmacokinetics 60 (5) (2020)
Lu Yu, Mingyu Xu, Wenwen Xu, Wei Xiao, Xue-Hua Jiang, Ling Wang, Huile Gao
Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles. Nano letters 20 (12) (2020)
Wenya Hu, Mi Jia, Siyan He, Huiru Xie, Xuehua Jiang, Ling Wang
Simultaneous determination of tandospirone and its active metabolite, 1-[2-pyrimidyl]-piperazine in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. Biomedical chromatography : BMC 33 (7) (2019)
Liang Zheng, Miao Xu, Shi-Wei Tang, Hao-Xin Song, Xue-Hua Jiang, Ling Wang
Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization. Pharmaceutical research 36 (12) (2019)
Suqin Feng, Liang Zheng, Shiwei Tang, Juan Gu, Xuehua Jiang, Ling Wang
In-vitro and in situ assessment of the efflux of five antidepressants by breast cancer resistance protein. The Journal of pharmacy and pharmacology 71 (7) (2019)
Yujie Yang, Lei Liu, Xiqian Zhang, Xuehua Jiang, Ling Wang
Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
Yujie Yang, Yanran Wang, Ting Wang, Xuehua Jiang, Ling Wang
Screening active components of modified Xiaoyao powder as NRF2 agonists. Cell biochemistry and function 35 (8) (2017)

Ling Wang.css-eqlu8i{font-size:small;padding-left:4px;} (L Wang)

Publication Activity (10 Years)

Top Topics

Top Venues

Ling Wang (L Wang)